Cargando…
Novel Anticancer Strategies II
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959780/ https://www.ncbi.nlm.nih.gov/pubmed/36839927 http://dx.doi.org/10.3390/pharmaceutics15020605 |
_version_ | 1784895362607087616 |
---|---|
author | Bousbaa, Hassan |
author_facet | Bousbaa, Hassan |
author_sort | Bousbaa, Hassan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9959780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99597802023-02-26 Novel Anticancer Strategies II Bousbaa, Hassan Pharmaceutics Editorial MDPI 2023-02-10 /pmc/articles/PMC9959780/ /pubmed/36839927 http://dx.doi.org/10.3390/pharmaceutics15020605 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Editorial Bousbaa, Hassan Novel Anticancer Strategies II |
title | Novel Anticancer Strategies II |
title_full | Novel Anticancer Strategies II |
title_fullStr | Novel Anticancer Strategies II |
title_full_unstemmed | Novel Anticancer Strategies II |
title_short | Novel Anticancer Strategies II |
title_sort | novel anticancer strategies ii |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959780/ https://www.ncbi.nlm.nih.gov/pubmed/36839927 http://dx.doi.org/10.3390/pharmaceutics15020605 |
work_keys_str_mv | AT bousbaahassan novelanticancerstrategiesii |